The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model
Open Access
Abstract
The administration route affects the biodistribution of a gene transfer vector and the expression of a transgene. A simian adenovirus 1 vector carrying firefly luciferase and GFP reporter genes (SAdV1-GFluc) were constructed, and its biodistribution was investigated in a mouse model by bioluminescence imaging and virus DNA tracking with real-time PCR. Luciferase activity and virus DNA were mainly found in the liver and spleen after the intravenous administration of SAdV1-GFluc. The results of flow cytometry illustrated that macrophages in the liver and spleen as well as hepatocytes were the target cells. Repeated inoculation was noneffective because of the stimulated serum neutralizing antibodies (NAbs) against SAdV-1. A transient, local expression of low-level luciferase was detected after intragastric administration, and the administration could be repeated without compromising the expression of the reporter gene. Intranasal administration led to a moderate, constant expression of a transgene in the whole respiratory tract and could be repeated one more time without a significant increase in the NAb titer. An immunohistochemistry assay showed that respiratory epithelial cells and macrophages in the lungs were transduced. High luciferase activity was restricted at the injection site and sustained for a week after intramuscular administration. A compromised transgene expression was observed after a repeated injection. When these mice were intramuscularly injected for a third time with the human adenovirus 5 (HAdV-5) vector carrying a luciferase gene, the luciferase activity recovered and reached the initial level, suggesting that the sequential use of SAdV-1 and HAdV-5 vectors was practicable. In short, the intranasal inoculation or intramuscular injection may be the preferred administration routes for the novel SAdV-1 vector in vaccine development.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2307900, 82161138001)
- National Natural Science Foundation (2023YFC2307900, 82161138001)
This publication has 52 references indexed in Scilit:
- Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccinesCurrent Opinion in Immunology, 2023
- Human adenovirus type 26 basic biology and its usage as vaccine vectorReviews in Medical Virology, 2022
- Isolation and Culture of Mouse Hepatocytes and Kupffer Cells (KCs)2022
- Adenovirus – a blueprint for gene deliveryCurrent Opinion in Virology, 2021
- Lessons learned from adenovirus (1970–2019)FEBS Letters, 2019
- Innate immunity to adenovirus: lessons from miceFEBS Letters, 2019
- Construction of an infectious clone of human adenovirus type 41Archives of Virology, 2012
- The influence of innate and pre‐existing immunity on adenovirus therapyJournal of Cellular Biochemistry, 2009
- Adenoviral VectorsCurrent Protocols in Human Genetics, 2004
- Expression of the Adenovirus Receptor and Its Interaction with the Fiber KnobExperimental Cell Research, 2000